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An online, voluntary, and anonymous survey 
was distributed to providers including 
physicians, fellows, nurse practitioners, and 
physician assistant in obstetrics/gynecology, 
cardiology, family medicine and internal 
medicine departments between October 2016 
and December 2016. The questionnaire is an 
adaption from a previously validated survey that 
tested the knowledge of PEC. All information 
had been verified to be consistent with the 
American Hearts Association and Centers for 
Disease Control and Prevention. Responses 
were collected via online software, Qualtrics 
and analyzed using descriptive and inferential 
statistics. 
Preeclampsia (PEC), pregnancy induced hyper-
tension (PIH) and gestational diabetes (GDM) has 
been recently identified as novel cardiovascular 
disease (CVD) risk factors for the development 
of heart disease in women.1,2  These conditions 
actually double the risk of developing heart 
disease and stroke over the next 5-15 years 
after pregnancy.3 Research shows that 18.2% of 
women with history of PEC had a cardiovascular 
event in 10 years following pregnancy compared 
to 1.7% of women without PEC. In light of these 
novel CVD risk factors, this provides a unique 
opportunity for health providers to intervene 
and bridge the knowledge gap and address 
the health disparity. Unfortunately, there is little 
information about the knowledge of provider in 
the Lehigh Valley area regarding the future health 
risk of pregnancy complications and current 
guidelines on treatment and counseling patients 
post pregnancy. 
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Methods
 
Overall completed response rate was 68% (111/162) with representation from obstetrics/gynecology 
(22%), maternal fetal medicine (3.67%), cardiology (15.60%), family medicine (2.675%), and internal 
medicine (55%) who was mostly comprised of physicians (34.23%) and residents (26.13%). Survey 
demonstrated majority of the providers were aware of the novel cardiovascular risk factors GDM 
(84.25%), PIH (86.3%), and PEC (82.88%) and its cardiovascular complication. Despite this knowledge, 
68% of providers counsel females with history of PEC about future cardiovascular risk 0-20% of the 
time. Of those who perceived presence of barriers in addressing these concerns, lack of knowledge 
(80%) and time (60%) were the primary factors. Many providers are uncomfortable counseling these 
patients (43.81%) and are interested in further education of PEC (79.34%).
Results
 
Although most providers were aware of the association between PEC, PIH, and GDM with 
future cardiovascular risks, they are not comfortable addressing their patients about these 
issues, possibly due to lack of knowledge and time. Correspondingly, after identifying 
women with history of PEC, majority rarely counsels their patients about the risks. The 
study indicates providers are interested in learning more about these novel risk factors and 
the associations to future CVD risk and argues for improving provider’s education in regards 
to this topic. We believe, the development of office tools to help address these concerns are 
necessary and can consequently increase providers’ comfort level when addressing risk 
reduction counseling and prevention for women.
Conclusion
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 This study aimed to assess provider’s awareness, knowledge, and perceptions regarding pregnancy 
complications with maternal long-term adverse 
cardiovascular outcomes and prevention of heart 
disease. Additionally, we assessed providers’ 
preference for distribution of information for 
future education.
Objective
Figure 1. Are the following cardiovascular risk factors in women? Figure 2. If a woman reports a history of preeclampsia, how often do 
you counsel her about her future risk of cardiovascular disease? 
Figure 3. Education Preferences and Comfort Level Figure 4. What are the barriers you face in addressing cardiovascular 
risk in women with history of preeclampsia? 
Figure 5. What do you think will be beneficial office tools for 
educating your patients about preeclampsia risk factors? 
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